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Despite the important role that mechanical forces play in tumor growth and therapy, the contribution of swelling to
tumor mechanopathology remains unexplored. Tumors rich in hyaluronan exhibit a highly negative fixed charge
density. Repulsive forces among these negative charges as well as swelling of cancer cells due to regulation of
intracellular tonicity can cause tumor swelling and development of stress that might compress blood vessels,
compromising tumor perfusion and drug delivery. Here, we designed an experimental strategy, using four
orthotopic tumor models, to measure swelling stress and related swelling to extracellular matrix components,
hyaluronan and collagen, as well as to tumor perfusion. Subsequently, interventions were performed to measure
tumor swelling using matrix-modifying enzymes (hyaluronidase and collagenase) and by repurposing pirfenidone,
an approved antifibrotic drug. Finally, in vitro experiments on cancer cell spheroids were performed to identify their
contribution to tissue swelling. Swelling stress was measured in the range of 16 to 75 mm Hg, high enough to
cause vessel collapse. Interestingly, while depletion of hyaluronan decreased swelling, collagen depletion had the
opposite effect, whereas the contribution of cancer cells was negligible. Furthermore, histological analysis
revealed the same linear correlation between tumor swelling and the ratio of hyaluronan to collagen content when
data from all tumor models were combined. Our data further revealed an inverse relation between tumor perfusion
and swelling, suggesting that reduction of swelling decompresses tumor vessels. These results provide guidelines
for emerging therapeutic strategies that target the tumor microenvironment to alleviate intratumoral stresses and
improve vessel functionality and drug delivery.
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Finding the cure for cancer is a true challenge undertaken by
hundreds of research groups worldwide, each one focusing on
different aspects of the disease in an attempt to better understand the
mechanism of cancer progression and identify a more effective
therapy. From the mechanical point of view, all tumor components
interact with each other, resulting in generation of mechanical stresses
between them that could elucidate disease pathogenesis. Mechanical
stresses stem either from the solid components of a tumor, mainly
cancer and stromal cells and the extracellular matrix (ECM), or from
the interstitial fluid. In the former case, the stress of the solid,
structural tumor components is known as solid stress, whereas the
stress from the interstitial fluid is referred to as the interstitial fluid
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components: stress owing to reciprocal interactions between the
tumor and the host tissue, residual stress, and swelling stress [2,3].
Solid stress is usually elevated in tumors because of tumor growth in
the confined space of the host tissue, which in turn resists tumor
expansion. Another cause of solid stress is the stiffening of the tumor,
observed in many cancers during tumor progression and the
accumulation of residual stresses [1–3]. Additionally, tumors rich in
hyaluronan (e.g., breast and pancreatic cancers and sarcomas) are
characterized by a high-net negative charge density owing to the
negatively charged groups of hyaluronan, quantified as the fixed charge
density (FCD) [4]. Because of its negative charge, hyaluronan
immobilizes interstitial fluid forming gel-like regions within the tissue
[5]. Repulsive electrostatic forces among the closely spaced negative
groups cause the swelling of these regions — an effect known as
chemical expansion—which in turn generates a swelling solid stress (or
swelling stress for brevity) because it is generated by solid components of
a tumor. IFP is also elevated owing to the hyperpermeability of some
tumor blood vessels, which allows excessive plasma to enter the tumor,
and due to the dysfunction of most intratumoral lymphatic vessels,
which cannot drain adequately the interstitial fluid [6,7]. Additionally,
in hyaluronan-rich tumors, because of the presence of FCD and in order
for the tumor to meet the electroneutrality condition, a large number of
counter ions must be present within the interstitial space. Therefore,
there might be an excess of cations within the tumor interstitial space,
creating a Donnan osmotic fluid pressure difference between the
internal and external environment of the tissue [8,9].
Elevated solid and fluid stresses determine in large part tumor
progression and response to treatment [2,10]. On one hand, elevated
solid stresses can directly compress cancer cells to reduce their
proliferation rate and increase their invasiveness and metastatic
potential [11–16]. These stresses can also compress intratumoral
blood and lymphatic vessels and thus cause hypoxia and hypoper-
fusion [1,17,18]. Hypoxia, among other effects, imposes a survival
advantage for cancer cells, enhances their ability to invade and
metastasize, harbors the cancer stem cells, and compromises the
efficacy of radiotherapy [19]. Hypoperfusion drastically reduces the
systemic delivery of drugs to the tumor site and, consequently, the
efficacy of chemo- and nanotherapeutics [20]. On the other hand,
elevated IFP poses an additional barrier to the delivery of nanoscale
drugs and facilitates transport of growth factors and cancer cells from
the tumor to the surrounding tissue, fueling tumor growth,
progression, and lymphatic metastasis [21,22]. Alleviation of solid
and fluid stresses by targeting specific components of the tumor
microenvironment has emerged as a new therapeutic strategy to
enhance cancer therapy with promising preclinical data [3,20,23–27]
and the first clinical trial being already in progress (clinicaltrials.gov
identifier NCT01821729). Preclinical studies have shown that
therapeutic depletion of collagen and/or hyaluronan alleviates
mechanical stresses and thus decompresses tumor blood vessels,
improving perfusion and the efficacy of chemotherapy [23–28].
Despite these encouraging findings, there are no established
guidelines on the use of stress alleviation strategies yet owing in
large part to our limited knowledge of tumor mechanical behavior
and its relation to tumor pathophysiology [2,29,30]. Therefore, it is
high time for in-depth understanding, analysis, and better character-
ization of all mechanical components of the tumor microenvironment
that contribute to the acquisition of malignant properties and drug
resistance to develop new and effective therapeutic interventions.Interestingly, little is known regarding the swelling behavior of
tumors, as there are only a few studies reporting osmotic fluid
pressure measurements [31], whereas to the best of our knowledge,
there is no study to measure and characterize the swelling stress. To
this end, we designed and performed a series of experiments and
developed a mathematical model to quantify the swelling behavior of
tumors, hereafter referred to as tumor swelling. Our objectives were to
relate tissue swelling to the composition and organization of the
tumor ECM and the functionality of the tumor vessels, compare
swelling stress and osmotic pressure to the total solid stress and IFP,
investigate how modifications of the ECM affect swelling and
perfusion, and identify the contribution of cancer cells to tumor
swelling. In that regard, we employed four orthotopic tumor models:
three xenograft models using the human breast MCF10CA1a,
pancreatic MiaPaCa2 and fibrosarcoma HT1080 cell lines and a
syngeneic model using the mouse 4T1 breast cancer cell line.
Furthermore, cancer cell spheroid models were generated to measure
swelling of cancer cells in vitro. Finally, because the component of the
solid stress owing to interactions with the host tissue and the osmotic
fluid pressure cannot be measured experimentally, we developed a
triphasic biomechanical mathematical model of tumor growth, which
accounted for the solid and fluid phase of the tumor as well as the
transport of ions and the fixed charged density. The model was
informed and specified using our experimental data and predicted
the contribution of each stress type to the mechanics of cancer
during progression.
Materials and Methods
Cell Culture
MCF10CA1a human breast cancer cell line was obtained from the
Karmanos Cancer Institute (Detroit, MI) and maintained as
previously described [32]. 4T1 mouse mammary carcinoma,
HT1080 human fibrosarcoma, and MiaPaCa2 pancreatic cell lines
were purchased from ATCC. 4T1 cells were maintained in RPMI
medium supplemented with 10% fetal bovine serum and 1%
penicillin/streptomycin, whereas the other cell lines were maintained
in Dulbecco's modified Eagle's medium supplemented with 10%
fetal bovine serum and 1% penicillin/streptomycin.
Animal Tumor Models and Experimental Protocols
All experimental protocols were approved by the Cyprus
Veterinary Services, the Cyprus national authority for monitoring
animal research, under a license (no. CY/EXP/PR.L1/2014).
Orthotopic xenograft breast tumors were generated by implantation
of 5 × 105 human MCF10CA1a cells resuspended in 40 μl of
serum-free medium into the mammary fat pad of 6-week-old female
CD1 nude immunodeficient mice. Orthotopic syngeneic models
were generated by implantation of 105 4T1 mouse mammary cancer
cells into the mammary fat pad of 6-week-old BALB/c female mice.
Orthotopic fibrosarcoma tumors and ectopic pancreatic tumors were
established by subcutaneous implantation of 5 × 106 human
HT1080 cells or 2 × 106 MiaPaCa2 cells, respectively, into the left
flank of 6- to 8-week-old NOD/SCID mice. Tumor growth was
monitored every second day, and the planar dimensions (x, y) were
measured with a digital caliper. Tumor volume was calculated using
the volume of an ellipsoid and assuming that the third dimension, z,
is equal to
ﬃﬃﬃﬃﬃ
xy
p
. The establishment of human orthotopic pancreatic
tumors was performed by surgical implantation of MiaPaCa2 cells
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that were anesthetized by intraperitoneal injection of Avertin
(250 mg/kg). Briefly, an incision of the skin was performed in the
area above the spleen, followed by a small cut on the surface of the
abdominal cavity. Then, the spleen along with the underlying
pancreas was gently pulled out, and the entire pancreatic body was
exposed. The organ was slightly spread using forceps, and 2.5 × 106
MiaPaCa2 cells resuspended in 20 μl of serum-free medium were
implanted in the pancreas [33]. Upon implantation, the abdominal
surface and skin were sutured.
Measurement of Swelling Solid Stress and Elastic Modulus in
Murine Tumors
The experimental setup was in line with other studies [8] and based
on the confined compression experiment using a high-precision
mechanical testing system (Instron 5944, Norwood, MA). Tumors
were excised with a scalpel into specimens of cylindrical shape, 4 mm
in diameter and 5 mm long, and they were placed into a chamber
(Figure 1 and Supplementary Figures S1 and S2). Therefore, each
tumor was divided into three to four pieces, and experiments were
performed on all of them. In total, 20 tumors were used from each
tumor type (n =20). At the top side of the chamber, a piston was
adjusted to compress the specimen. At the bottom side of the
chamber, a filter paper (Whatman, 20- to 25-μm pore size) was
placed to allow fluid flow. Special care was taken to ensure that the
tumor was never in direct contact with fluid during storage so as to
minimize potential leakage of FCD from the specimen before testing.
The sample was initially compressed to 10% strain in a period of 2
minutes to make sure the piston applies well on the specimen and that
the specimen's response to deformations is measurable. Afterward, the
specimen was held for 20 minutes until the stress relaxed and reached
an equilibrium. Subsequently, the specimen was kept at the same
strain, and NaCl dissolved in ultrapure water was added to the chamber
at concentrations ranging from 0.001 to 0.3 M (Figure 1). Upon
addition of NaCl, the stress increased and reached a new equilibrium.
Swelling stress was quantified as the change in stress following NaCl1
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This allowed for the measurement of the elastic modulus of
the specimen from the slope of the stress-strain curve between
10% and 15% compression (Figure 1). As a reference condition for
all measurements, we used the physiological ionic concentration
(0.15 M) where tumor swelling is considered to be zero [8].
Cancer Cell Spheroids Formation and Swelling Measurement
MiaPaCa2 and HT1080 cell spheroids were formed using the
“hanging drop” technique, as described previously (Supplementary
Material [34,35]). Subsequently, formed spheroids were transferred
into wells of a 96-well plate containing 1% agarose using a glass
Pasteur pipette. Pictures were then taken using a Nikon Eclipse
optical microscope; this was considered as time zero. Subsequently,
NaCl solutions of different molarity were added on top of the
spheroids, and they were incubated for an additional hour at 37°C.
Hypotonic NaCl solution had a concentration of 0.001 M; isotonic, a
concentration of 0.15 M; and hypertonic, a concentration of 0.3 M.
Pictures were taken at the 1-hour time point, as this proved to be
sufficient for cells to equilibrate, and changes in spheroids' size
(average of the major and minor axis length) were measured using the
ImageJ software. Two independent experiments were performed, and
at least six spheroids were monitored for each NaCl condition.
Fluorescent Immunohistochemistry
Seven minutes prior euthanization and tumor removal, mice were
slowly injected with 100 μl of 1 mg/ml of biotinylated Lycopersicon
esculentum (tomato) lectin (Vector Labs) via intracardiac injection.
Following swelling measurements, tumor specimens were fixed with
4% paraformaldehyde in PBS for 20 minutes at room temperature
followed by overnight incubation at 30% sucrose in PBS at 4°C. The
samples were then embedded in optimal cutting temperature
compound (Tissue-Tek) and frozen.
Collagen and Hyaluronan Analysis. Transverse 40-μm–thick
tumor sections were cut and immunostained with collagen I antibody
(ab4710, Abcam 1:100 dilution) and hyaluronan (ab53842, Abcam0 1000 2000 3000 4000 5000
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(Vector Labs). Collagen I was detected with Alexa Fluor-647 Goat
Anti-Rabbit IgG (H + L) secondary antibody (A-21244, Invitrogen,
1:800 dilution), and hyaluronan was detected using Alexa Fluor-647
donkey Anti-sheep IgG (H + L) secondary antibody (A-11015,
1:800 dilution).
Blood Perfusion Analysis. Transverse 60-μm–thick tumor sec-
tions were prepared and counterstained with antibody against the
endothelial marker CD31 (MEC13.3 antibody, Biosciences [BD],
1:100 dilution). Lectin staining was detected using the Streptavidin
Alexa Fluor 488 conjugate (Molecular Probes, S11223, 1:400
dilution), and CD31 signal was detected with Alexa Fluor-647
Goat Anti-Rat IgG (H + L) secondary antibody (Molecular Probes,
A-21247, 1:800 dilution). Perfused vessel fraction was calculated as
the ratio of the perfused vessel area (lectin and CD31-positive vessels)
to the total area of vessels (CD31-positive vessels). For image analysis,
the calculation of collagen and hyaluronan area fractions and fraction
of perfused vessels was performed automatically using a previously
developed in-house code in MATLAB (MathWorks, Inc., Natick,
MA) to avoid any associated bias [3,23]. Furthermore, to deal with
the spatial heterogeneity of the tissues, five sections were taken from
each specimen starting from tumor center toward the periphery.
IFP Measurement
IFP was measured in vivo with the wick-in-needle technique [36].
Statistical Analysis
The data are presented as means with standard errors. Groups were
compared using Student's t test.
Mathematical Model
Based on our previous work [1,29,30,37,38], a mathematical
model was developed and informed by our experimental data to
calculate the Donnan osmotic pressure and the solid stress exerted by
the host tissue on the tumor, which cannot be measured
experimentally. The model consisted of three phases: the solid and
fluid phase and the ions (positive and negative). Furthermore, it
employed the multiplicative decomposition of the deformation
gradient tensor to model tumor growth, accounting also for the
effect tumor oxygenation and solid stress on cancer cell proliferation
[38–40]. A detailed description of the mathematical model is given in
the Supplementary Material.
Results
Swelling Stress Is Evident in All Tumor Models and Increases
with Hypotonic Conditions
Tomeasure the swelling stress of the four orthotopic tumormodels as
a function of the concentration of electrolytes, we designed an
experimental approach as depicted in Figure 1, A and B. A typical tissue
response is shown in Supplementary Figure S2. The swelling stress
increased upon addition of hypotonic saline, whereas it remained stable
at zero upon addition of isotonic or hypertonic solutions (Figure 2). As
hypotonic solutions exhibit low ionic strength, the Debye length that
defines the range of electrostatic interactions increases. For NaCl
concentrations closer to or higher than the physiological value of 0.15
M, the electrostatic repulsive forces become negligible owing to the
small value of the Debye length (~0.8 nm), and thus, no swelling was
observed. For the lowest concentration of NaCl, the swelling stress
ranged from 16.01 ±1.66 mmHg (2.13 ± 0.22 kPa) for the MiaPaCa2tumors to 75.38 ± 9.03 mmHg (10.05 ± 1.20 kPa) for the HT1080.
To confirm that the experimental measurements of the swelling stress
did not include any component of Donnan osmotic pressure, we
simulated the experimental procedure using our mathematical model.
The simulations showed that Donnan osmotic pressure should be
negligible (Supplementary Figure S3).
As far as the elastic modulus is concerned, in all tumor types, it
exhibited a dependence on NaCl concentration (Supplementary
Figure S4). The modulus was higher at low electrolyte concentrations,
whereas it dropped to a constant value at higher concentrations, with
the exception of MiaPaCa2 tumors in which it remained unaltered for
all spectra of electrolyte concentrations. Swelling stress and elastic
modulus fitted well to phenomenological expressions previously
employed for cartilage swelling (Supplementary Equations S5 and
S14) [8]. The values of the parameters of the equations are given in
Supplementary Table S1.
Tumor Swelling Increases Linearly with the Ratio of Hyaluronan
to Collagen Area Fraction
To investigate the ECM structure of the tumor types studied,
immunofluorescence analysis of collagen and hyaluronan was
performed. Even though other types of glycosaminoglycans might
contribute to tumor swelling, we focused on the examination of
hyaluronan owing to its abundance in the tumors tested and because
it has been reported to be a target for stress-alleviating therapeutic
strategies [23–25]. MiaPaCa2 and HT1080 tumors had higher
levels of collagen and hyaluronan compared with the two breast
tumor types, MCF10CA1a and 4T1 (Figure 3A and Supplementary
Figure S5). As the data of the lowest electrolyte concentration (0.001
M) exhibited the largest variation in swelling, they were selected for
further analysis. Thus, correlations between the swelling stress and the
composition of the tumor ECM were sought. There was no
correlation between swelling and hyaluronan or collagen content
alone (Figure 3, B and C). Interestingly however, when swelling stress
was plotted as a function of the relative area fraction of hyaluronan to
collagen, a strong linear correlation was revealed that was verified in
all tumor types tested (Figure 3D), indicating a dependence of tissue
swelling on tumor's collagen and hyaluronan composition. This
finding is in accordance with in vivo studies in cartilage tissue as well
as with studies using in vitro models [41–43].
Swelling Contributes to Tumor Mechanical Function Contrary
to Negligible Donnan Osmotic Pressure
Contrary to swelling stress and IFP that can be measured
experimentally, there is no in vivo or ex vivo technique to measure
the solid stress owing to mechanical interactions of the tumor with the
host tissue and the Donnan osmotic pressure. As mentioned above, to
assess all components of mechanical stress and investigate their
contribution to tumor mechanics, we developed a triphasic
biomechanical model of tumor growth (details in Supplementary
Material). The solid phase was modeled as a compressible
neo-Hookean material with a Poisson's ratio of 0.45 [1], and the
elastic modulus was taken by the experimental data accounting for the
dependence on ion concentration (Supplementary Figure S4 and
Equation S5). The fluid phase was modeled as ideal (i.e., of no
viscosity) and governed by Darcy's law [1]. The hydraulic
conductivity of the tumor appearing in Darcy's law was defined by
fitting the model to the IFP experimental data (Supplementary
Figure S6). To determine the values of model parameters related to
Figure 2. Experimental data of tumor swelling. Swelling stress as a function of NaCl concentration for the four orthotopic tumor models
employed in the study. The experimental data were fitted to Eq. (S14) (solid line) and values of the fitting parameters are shown in
Supplementary Table S1.
Figure 3. Effect of ECM composition on swelling stress. (A) Representative immunofluorescence staining sections for hyaluronan (HA)
and collagen (scale bar 100 μm), (B) Swelling stress as a function of HA area fraction, and (C) collagen area fraction showing no
correlation. (D) Swelling stress is linearly proportional to the ratio of HA/collagen area fraction (y = 4.089x − 2.057, R2 = 0.825). Five
tumor specimens (n = 5) from each tumor type were used.
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tumor growth (Supplementary Figure S7 and Table S1).
Model predictions for the solid stress, swelling stress, IFP, and
osmotic pressure during tumor progression are shown in Figure 4 and
Supplementary Figure S8 for MCF10CA1a and 4T1 tumors,
respectively. In both tumor types, the compressive solid stress exerted
externally on the tumor by the host was in the order of 300 mmHg
(40 kPa), and the swelling stress was ~52.5 mmHg (7 kPa) for
MCF10CA1a and ~25.13 mmHg (3.35 kPa) for the 4T1 tumors.
IFP calculations were similar to the experimental measurements, i.e.,
in the range of 4.5 to 5.2 mmHg (0.6-0.7 kPa) (Figure 4 and
Supplementary Figure S6), and the calculated Donnan osmotic
pressure ranged from 0.52 to 0.6 mmHg (0.07-0.08 kPa). Therefore,
our calculations indicated that solid stress (external and swelling) is
much larger than interstitial fluid pressure and that swelling stress can
be important to tumor mechanics, whereas Donnan osmotic pressure
is negligible.
To further explore the predictive capabilities of the model, a
parametric analysis was performed varying the hydraulic conductivity of
the tumor and the initial concentration of fixed charges that mostly
affectmodel predictions (Supplementary Figures S9 and S10). From the
analysis, we conclude that model results only change quantitatively.
Enzymatic and Drug-Mediated Reduction of ECM Components
Modulates Tumor Swelling
To further investigate the contribution of collagen and hyaluronan
to tumor swelling, we treated ectopic MiaPaCa2 and orthotopic0 1 2 3 4 5 6 7
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osmotic fluid pressure as a function of the radial position from tumor
tumors. External solid stress is compressive in the tumor interior and
and temporally uniform, IFP increases with time owing to increased ve
whereas osmotic pressure is negligible.HT1080 tumors with enzymes (collagenase and hyalurodinase) as
well as with pirfenidone (Esbriet), a drug prescribed for idiopathic
pulmonary fibrosis. Intratumoral injection of 1000 U in 50 μl of
collagenase or 25 μg in 50 μl of hyaluronidase 2 hours prior to tumor
removal significantly reduced collagen and hyaluronan levels (Pb.05)
respectively, whereas daily oral administration of 500 mg/kg
pirfenidone reduced significantly levels of both constituents, Pb.05
(Figures 5, A–C). Interestingly, our results show that swelling of
hyaluronidase-treated tumors reduced drastically to negligible levels,
that of pirfenidone-treated tumors decreased, whereas the swelling of
collagenase-treated tumors increased (Figure 5D). Hence, the
observed swelling response is exclusively due to hyaluronan, and
collagen itself restricts swelling.
Tumor Swelling Inversely Correlates with Blood Vessel
Functionality
Solid stress can compress intratumoral blood vessels, reducing their
diameter and tumor perfusion [6,44]. To investigate any potential
correlation of swelling to tumor perfusion, we examined perfused
vessels by administering biotinylated lectin to mice via intracardiac
injection prior to tumor removal for all tumor types and treatment
conditions tested. Interestingly, there is an inverse relationship, well
expressed by an exponential decay function, between the perfused
vessel fraction and the swelling stress (Figure 5E). A similar inverse
correlation between tumor perfusion and the tumor ECM fraction
has also been shown previously in pertinent research [23].
Interestingly, hyaluronidase treatment radically reduced tumor0 0.5 1 1.5 2 2.5 3 3.5 4 4.5 5
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ssel permeability and drops to normal (zero) values at the periphery,
Figure 5. Effect of tissue swelling on vessel perfusion. (A) Representative immunofluorescence staining sections for hyaluronan (HA) and
collagen (scale bar 100 μm), (B) typical immunofluorescence staining sections for lectin and CD31 (scale bar 100 μm), (C) area fraction of
collagen and HA, and (D) swelling stress for the control and treated tumors tested. Changes in stress between the control and each of the
treated groups are statistically significant (P b .05) for both tumor types. (E) Fraction of perfused vessels as a function of tumor swelling
showing their exponential decay relationship (dash line, y = −27.22e(−21.49x), R2 = 0.8913) and also the different mechanism of collagen
reduction to improve perfusion (dash circle).
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Collagen reduction following collagenase treatment, on the other
hand, was associated with improved perfusion even though the tumor
exhibited increased swelling stress, thus implying a different
mechanism of action. This could be due to the fact that collagenfibers restrict tissue swelling and their depletion allows the tumor to
further swell and relax, alleviating intratumoral swelling stresses.
Pirfenidone treatment also resulted in improved perfusion, showing
that repurposing of common antifibrotic drugs can be used to
enhance perfusion and drug delivery, ultimately improving therapy.
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Recent work by McGrail et al. showed that cancer cells regulate
their tonicity and swell to survive and resist compressive forces that
are developed in the tumor's interior [45]. To determine whether
cancer cell swelling can account for the changes we observe in tumor
swelling, we employed an in vitro model. Specifically, MiaPaCa2 and
HT1080 cancer cells were used to generate tumor spheroids that were
embedded in a 1% agarose matrix, and changes in the spheroids' size
were recorded in relation to changes in osmolarity. Our findings
show that cancer cell spheroids swelled by approximately 70% to
80% for a hypotonic solution (0.001 M, NaCl) and shrunk by 60%
to 70% when the solution was changed to hypertonic (0.3 M, NaCl)
(Figure 6, A and B). To convert the observed deformations to
stresses, we measured the mechanical properties of the agarose gel and
found the Young's modulus to be 3.6 ± 0.56 kPa (Figure 6C).
Subsequently, using our mathematical model, the growth of the
spheroids within the agarose matrix was simulated, and the stress
developed in the spheroids was calculated. Figure 6D presents the
calculated by the model stress for varying the elastic properties
(Young's modulus) of cancer cell spheroids with values taken from the
literature [40]. According to our calculations, cancer cell swelling
should not contribute to tissue-level swelling of the tumor.
Discussion
It has been well established that mechanical forces modulate the
tumor microenvironment and pathophysiology and determine in
large part tumor progression and response to therapy [2,46].
However, there has been no study to date to describe the swellingFigure 6. Cancer cell swelling (A) microscope image of a spheroid. Lin
after addition of electrolyte solution. (B) Change in spheroid's diameter
(C) stress strain curve of 1% agarose gel, and (D) stress developed obehavior of tumors, the magnitude of swelling stress and Donnan
osmotic pressure, the dependence of swelling on tissue composition,
and its contribution to tumor perfusion, which play a critical role in
the efficacy of cancer therapy [47,48]. Here, we performed a series of
in vivo and in vitro experiments coupled with mathematical modeling
to elucidate these issues. We found that swelling is evident in breast,
pancreatic, and sarcoma cell lines and that it is high enough to
compress intratumoral blood vessels and affect tumor perfusion.
Interestingly, our analysis revealed the same linear correlation
between swelling stress and the ratio of hyaluronan to collagen
content for all tumor types tested, suggesting that tumor swelling is
mainly due to the ECM composition. This conclusion was further
supported by the finding that tumors treated with hyaluronidase
exhibited negligible swelling, whereas swelling was increased in
tumors treated with collagenase. This can be explained by the fact that
collagen fibers are stressed during swelling and hinder tissue
expansion owing to their property to resist tensile loads. Moreover,
this observation regarding the role of collagen is consistent with
pertinent studies on cartilage [42,43] and a recent in vitro study [41].
Last but not least, in vitro experiments on tumor spheroids
showed that cancer cell swelling should not significantly contribute
to tumor swelling.
More importantly, we found that swelling affects tumor perfusion
and thus could be a significant factor affecting drug delivery.
Perfusion is compromised in many tumor types, particularly in
desmoplastic tumors (e.g., breast and pancreatic cancers and
sarcomas) that are considered to be rich in collagen and/or
hyaluronan, because of intratumoral blood vessel compressiones depict the perimeter of the spheroid before (0 hour) and an hour
as a function of the tonicity for HT1080 andMiaPaCa2 cancer cells,
n the spheroids as a function of their elastic modulus.
740 Swelling Behavior of Solid Tumors Voutouri et al. Neoplasia Vol. 18, No. 12, 2016[3,23,48]. Hypoperfusion in turn causes hypoxia, which promotes
tumor growth in multiple ways, and reduces the efficacy of radiation
therapy, immunotherapy, and chemo-/nanotherapy because of the
inability of oxygen, immune cells, and drugs to reach the tumor site in
sufficient amounts [19,47–49]. In previous research, we proposed
and proved experimentally that alleviation of solid stresses has the
potential to decompress tumor blood vessels and thus improve
perfusion [3,23]. In this work, we found that swelling stress is high
enough to cause vessel compression and that modulation of swelling
stress levels can result in vessel decompression (Supplementary
Figure S12) and improved perfusion. Interestingly, our data indicated
that alleviation of tumor swelling by hyaluronan depletion and
increase in tumor swelling by reduction of collagen levels are two
different mechanisms to improve perfusion. Furthermore, we
demonstrated that the repurposing of commonly used antifibrotic
drugs could comprise a novel approach to improve delivery of
cytotoxic agents by enhancing perfusion.
Conclusively, this is a comprehensive study that provides new
insights on the mechanopathology of solid tumors, highlighting the
effect of tumor structure on the tissue function and pathophysiology
and the role of ECM components in tumor mechanical response and
tissue swelling in particular. Our findings and especially the direct,
linear correlation of swelling stress to tumor ECM content as well as
the inverse correlation of perfusion to tumor swelling provide novel
considerations for the use of stress alleviation strategies to modify the
microenvironment of solid tumors to enhance therapeutic outcome.
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